Revenue
-
Net Income
-$738.8M
▲ 12.7% YoY
EPS
$-6.86
▲ 26.1% YoY
Cash
$230.0M
▲ 132.0% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Gentile Kimberly SVP, Clinical Operations | Vest | Jan 5, 2026 | 3.8K | $0.00 | $0 | Form 4 ↗ |
Gentile Kimberly SVP, Clinical Operations | Sell tax | Jan 5, 2026 | 2.0K | $9.93 | $19K | Form 4 ↗ |
Buten Matthew Chief Financial Officer | Vest | Jan 5, 2026 | 4.3K | $0.00 | $0 | Form 4 ↗ |
Buten Matthew Chief Financial Officer | Sell tax | Jan 5, 2026 | 2.6K | $9.93 | $26K | Form 4 ↗ |
Coric Vlad Chief Executive Officer | Vest | Jan 5, 2026 | 14.3K | $0.00 | $0 | Form 4 ↗ |
Coric Vlad Chief Executive Officer | Sell tax | Jan 5, 2026 | 7.4K | $9.93 | $74K | Form 4 ↗ |
Car Bruce Chief Scientific Officer | Vest | Jan 5, 2026 | 4.8K | $0.00 | $0 | Form 4 ↗ |
Car Bruce Chief Scientific Officer | Sell tax | Jan 5, 2026 | 2.4K | $9.93 | $24K | Form 4 ↗ |
Clark George C. VP, Chief Accounting Officer | Vest | Jan 5, 2026 | 2.5K | $0.00 | $0 | Form 4 ↗ |
Clark George C. VP, Chief Accounting Officer | Sell tax | Jan 5, 2026 | 1.1K | $9.93 | $11K | Form 4 ↗ |